[1]
|
Bielewicz, J., Kurzepa, J., Lagowska-Lenard, M., et al. (2010) The Novel Views on the Pathomechanism of Ischemic Stroke. Wiadomosci Lekarskie, 63, 213-220.
|
[2]
|
Li, Y. (2010) To Prevent and Treat Stroke Completely and Systematically and Reduce Its Damages. Shanghai Medical Journal, 9, 793-794.
|
[3]
|
Wang, H. and Cai, H. (2015) The Clinical Curative Effect Observation of Treating Acute Cerebral Infarction in the Very Early Stage with Acupuncture. Journal of Clinical Acupuncture and Moxibustion, 3, 31-32.
|
[4]
|
Murray, C.J. and Lopez, A.D. (2013) Measuring the Global Burden of Disease. The New England Journal of Medicine, 369, 448-457. https://doi.org/10.1056/NEJMra1201534
|
[5]
|
Yu, C., Luo, L., Li, M., et al. (2016) To Observe the Heavy Burden of Stroke in China from the View of the World. J Public Health Prev Med, 1, 1-5.
|
[6]
|
Liu, S. (2007) Analysis about the Effects of Treating Stroke with Hyperbaric Oxygen and the Related Sequela. Chinese Journal of Practical Internal Medicine, S1, 256-267.
|
[7]
|
Zhao, Y. (2011) Analysis about Prevention Measures for Stroke. Chinese Journal of Practical Nervous Diseases, 1, 52-53.
|
[8]
|
Gong, L. (2005) The Recent Situation of Researches about the Young Stroke. China Med Abstr., 2, 237-239.
|
[9]
|
Yang, G., Wang, Y., Zeng, Y., et al. (2013) Rapid Health Transition in China, 1990-2010: Findings from the Global Burden of Disease Study 2010. The Lancet, 381, 1987-2015. https://doi.org/10.1016/S0140-6736(13)61097-1
|
[10]
|
Ministry of Health of the PRC (2008) The Main Conditions of the Third Time National Death Inquiry. China Cancer, 5, 344-345.
|
[11]
|
Wang, Y., Wu, S., Gao, J., et al. (2012) The Influence of Ideal Cardiovascular Healthy Behaviors and Factors for New Ischemic Stroke. Chinese Journal of Hypertension, 4, 342-346.
|
[12]
|
Sandercock, P.A., Counsell, C., Tseng, M.C. and Cecconi, E. (2014) Oral Antiplatelet Therapy for Acute Ischaemic Stroke. Cochrane Database of Systematic Reviews, 3, CD000029. https://doi.org/10.1002/14651858.CD000029.pub3
|
[13]
|
Rothwell, P.M., Algra, A., Chen, Z., et al. (2016) Effects of Aspirin on Risk and Severity of Early Recurrent Stroke after Transient Ischaemic Attack and Ischaemic Stroke: Time-Course Analysis of Randomised Trials. The Lancet, 388, 365. https://doi.org/10.1016/S0140-6736(16)30468-8
|
[14]
|
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682.
|
[15]
|
Laine, M., Paganelli, F. and Bonello, L. (2016) P2Y12-ADP Receptor Antagonists: Days of Future and Past. World Journal of Cardiology, 8, 327. https://doi.org/10.4330/wjc.v8.i5.327
|
[16]
|
Scott, S.A., Sangkuhl, K., Gardner, E.E., et al. (2011) Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genoty Peandclopidogrel Therapy. Clinical Pharmacology & Therapeutics, 90, 328-332. https://doi.org/10.1038/clpt.2011.132
|
[17]
|
Meschia, J.F., Bushnell, C., Boden-Albala, B., et al. (2014) Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 45, 3754-3832. https://doi.org/10.1161/STR.0000000000000046
|
[18]
|
Lee, M., Saver, J.L., Hong, K.S., et al. (2013) Risk-Benefit Profile of Long-Term Dual- versus Single-Antiplatelet Therapy among Patients with Ischemic Stroke: A Systematic Review and Meta-Analysis. Annals of Internal Medicine, 159, 463-470. https://doi.org/10.7326/0003-4819-159-7-201310010-00006
|
[19]
|
Kernan, W.N., Ovbiagele, B., Black, H.R., et al. (2014) Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 45, 2160-2236. https://doi.org/10.1161/STR.0000000000000024
|
[20]
|
Jia, D.M., Chen, Z.B., Zhang, M.J., et al. (2013) CYP2C19 Polymorphisms and Antiplatelet Effects of Clopidogrel in Acute Ischemic Stroke in China. Stroke, 44, 1717-1719. https://doi.org/10.1161/STROKEAHA.113.000823
|
[21]
|
Gu, S., Sun, Y., Han, R., et al. (2014) Association between Genetic Polymorphisms of Cytochrome P450 2C19 and the Risk of Cerebral Ischemic Stroke in Chinese. BMC Medical Genetics, 15, 83. https://doi.org/10.1186/1471-2350-15-83
|
[22]
|
Serebruany, V.L., Steinhubl, S.R., Berger, P.B., et al. (2005) Analysis of Risk of Bleeding Complications after Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials. American Journal of Cardiology, 95, 1218. https://doi.org/10.1016/j.amjcard.2005.01.049
|
[23]
|
Lansberg, M.G., O’Donnell, M.J., Khatri, P., et al. (2012) Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e601S. https://doi.org/10.1378/chest.141.4.1129b
|
[24]
|
(2014) Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 45, 2160.
https://doi.org/10.1161/STR.0000000000000024
|
[25]
|
Greving, J.P., Diener, H.C., Reitsma, J.B., et al. (2019) Antiplatelet Therapy after Noncardioembolic Stroke. Stroke, 50, 1812. https://doi.org/10.1161/STROKEAHA.118.024497
|
[26]
|
Halkes, P.H., Gray, L.J., Bath, P.M., et al. (2008) Dipyridamole plus Aspirin versus Aspirin Alone in Secondary Prevention after TIA Orstroke: A Meta-Analysis by Risk. Journal of Neurology, Neurosurgery and Psychiatry, 79, 1218- 1223. https://doi.org/10.1136/jnnp.2008.143875
|
[27]
|
Diener, H.C., Cunha, L., Forbes, C., et al. (1996) European Stroke Prevention Study. 2. Dipyridamole and Acetylsalicylic Acid in the Secondary Prevention of Stroke. Journal of the Neurological Sciences, 14, 1-13.
https://doi.org/10.1016/S0022-510X(96)00308-5
|
[28]
|
Halkes, P.H., van Gijn, J., Kappelle, L.J., et al. (2006) Aspirin plus Dipyridamole versus Aspirin Alone after Cerebral Ischaemia of Arterial Origin (ESPRIT): Randomised Controlled Trial. The Lancet, 367, 1665-1673.
https://doi.org/10.1016/S0140-6736(06)68734-5
|
[29]
|
Foster, C.J., Prosser, D.M., Agans, J.M., et al. (2001) Molecular Identification and Characterization of the Platelet ADP Receptor Targeted by Thienopyridine Antithrombotic Drugs. Journal of Clinical Investigation, 107, 1591.
https://doi.org/10.1172/JCI12242
|
[30]
|
Cattaneo, M., Schulz, R. and Nylander, S. (2014) Adenosine-Mediated Effects of Ticagrelor: Evidence and Potential Clinical Relevance. Journal of the American College of Cardiology, 63, 2503-2509.
https://doi.org/10.1016/j.jacc.2014.03.031
|
[31]
|
Yamauchi, K., Imai, T., Shimazawa, M., et al. (2017) Effects of Ticagrelor in Amouse Model of Ischemic Stroke. Scientific Reports, 7, Article No. 12088. https://doi.org/10.1038/s41598-017-12205-w
|
[32]
|
Amarenco, P., Albers, G.W., Denison, H., et al. (2017) Efficacy and Safety of Ticagrelor versus Aspirin in Acute Stroke or Transient Ischaemic Attack of Atherosclerotic Origin: A Subgroup Analysis of SOCRATES, a Randomised, Double-Blind, Controlled Trial. The Lancet Neurology, 16, 301-310. https://doi.org/10.1016/S1474-4422(17)30038-8
|
[33]
|
Malhotra, K., Goyal, N. and Tsivgoulis, G. (2017) Internal Carotid Artery Occlusion: Pathophysiology, Diagnosis, and Management. Current Atherosclerosis Reports, 19, 41. https://doi.org/10.1007/s11883-017-0677-7
|
[34]
|
Powers, W.J., Rabinstein, A.A., Ackerson, T., et al. (2018) 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 49, e46-e110.
|
[35]
|
Johnston, S.C., Amarenco, P., Albers, G.W., et al. (2016) Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. The New England Journal of Medicine, 375, 35-43. https://doi.org/10.1056/NEJMoa1603060
|
[36]
|
Konark, M., Nitin, G., Alissa, S., et al. (2018) Ticagrelor for Stroke Prevention in Patients with Vascular Risk Factors: A Systematic Review and Meta-Analysis. Journal of the Neurological Sciences, 390, 212-218.
https://doi.org/10.1016/j.jns.2018.05.001
|